Semaglutide Peptide Raw Powder CAS 910463-68-2

Semaglutide Peptide Raw Powder is the seventh approved GLP-1 receptor agonist in the world. At the same time, it is also known as the strongest hypoglycemic agent in history.Studies have shown that semgalutide API is very similar to natural GLP-1, with only two structural differences: (1) the alanine amino acid at position 8 is replaced by A-aminoisobutyric acid, which makes the molecule more resistant to the degradation of DPP-4; (2) The introduced carbon chain is longer, and the flexible fatty chain conjugates C18 fatty diacid to lysine at position 26, thus improving the binding characteristics with albumin, which prolongs the life of Sermaglutide powder in plasma and reduces its renal clearance rate.

What does the hypoglycemic effect of Semaglutide Peptide Raw Powder mean?

GLP-1 is a brain gut peptide secreted by endocrine cells in the ileum. Research has shown that when GLP-1 binds to GLP-1 receptors, it can stimulate insulin secretion, inhibit the release of glucagon, and thus achieve hypoglycemic effects. At the same time, another important chemical substance, DPP-4, is involved in this process. The main function of DPP-4 is to degrade GLP-1 in the body and maintain a balance of GLP-1 levels in the body.
The study found that type II diabetes patients generally had insufficient secretion of GLP-1, and the insufficient GLP-1 further weakened the hypoglycemic function under the degradation of DPP-4, leading to a higher level of blood sugar in patients.
Therefore, there are two main approaches to lowering blood sugar: one is to develop DPP-4 inhibitors to inactivate DPP-4; The second is to develop biosimilars of GLP-1 to compensate for its shortcomings.
The representative products of DPP-4 inhibitors are Statins pharmaceutical raw materials, such as sitagliptin, vildagliptin, saxagliptin, and so on. In addition, its market price is also significantly lower than that of GLP-1 agonist, and it is convenient to use. It also does not have the risk of hypoglycemia and gastrointestinal adverse reactions, and has obvious advantages in targeting elderly patients with type II diabetes. However, its disadvantage is also that its effect is not very obvious, and it does not work in areas such as gastric emptying and appetite suppression.
Three months before the marketing of Semaglutide Peptide Raw Powder, that is, on September 12, 2017, the 53rd annual meeting of the European diabetes Association released a significant positive. After receiving weekly Sermaglutide treatment for patients with type II diabetes, the effect of reducing blood sugar and weight was significantly better than other products with similar functions. Especially in the head to head experiments with Statins pharmaceutical raw materials, semaglutide outperformed in both glycemic and weight loss indicators. In terms of adverse reactions, semaglutide only causes moderate nausea and vomiting, but this reaction will gradually disappear during its subsequent use.

How to choose between Semaglutide Peptide Raw Powder and Orlistat?

Sermaglutide and Orlistat are currently popular weight loss drugs, but there are significant differences between the two in terms of weight loss effectiveness, mechanism of action, and applicable population. Semaglutide Peptide Raw Powder achieves weight loss through multiple mechanisms such as delaying gastric emptying, suppressing appetite, and increasing satiety. The effect is more significant, with an average weight loss of 15% -18% after 68 weeks of continuous use. However, it is difficult to operate and expensive, and is mainly suitable for patients with BMI ≥ 30 or BMI ≥ 27 accompanied by complications in clinical practice. Orlistat API powder achieves weight loss by inhibiting fat absorption. It is easy to use and affordable, but the weight loss effect is relatively mild (about 10% weight loss in 6 months), and the gastrointestinal side effects are obvious (oily stool, increased exhaust). It is suitable for patients with BMI ≥ 28 or BMI ≥ 24 accompanied by risk factors. So, when we choose them, we need to consider their weight base, economic conditions, tolerance, and doctor's advice comprehensively, and cooperate with a healthy lifestyle, otherwise the effect will be poor and prone to recurrence.

Why choose Semaglutide Peptide Raw Powder first when lowering blood sugar?

Semaglutide has more advantages in cardiovascular protection. The latest research shows that Sermaglutide can reduce the risk of major cardiovascular adverse events (MACE) in patients with type 2 diabetes by 26%. Its cardiovascular protection mechanism includes multiple effects such as improving vascular endothelial function, anti-inflammatory, anti atherosclerosis, lowering blood pressure and improving blood lipid profile. In contrast, empagliflozin, as an SGLT2 inhibitor, mainly exerts cardiovascular protection through mechanisms such as diuresis and improvement of cardiac energy metabolism. It can reduce the risk of hospitalization for heart failure by 35% and the risk of cardiovascular death by 38%. Although both have clear cardiovascular benefits, Sermaglutide has a more significant weight loss effect (with an average weight loss of 15% -18% after 68 weeks of continuous use), and its cardiovascular protective effect is independent of the weight loss effect, showing better performance in reducing the risk of cardiovascular events. Especially for type 2 diabetes patients with cardiovascular disease, Semaglutide Peptide Raw Powder can be the priority.

A variety of shipping methods for you to choose

Our strengths:

Our company has passed FDA and ISO19001 quality management system certification. And we have internal cooperation agreements with multiple factories and laboratories in China,Our company can provide Semaglutide Peptide Raw Powder etc. at a more favorable price. If you are interested, please leave a message.
We not only have unique advantages in transportation, but also support multiple payment methods, whether you use US dollars, euros, Australian dollars, or local currencies from Singapore, Malaysia, Thailand, and so on. We can also support local currencies in these regions and countries. In addition, we also support bank cards (credit cards, etc.) for payments.

FAQ:

Q1: Can people with a BMI less than 30 use it?
Sure, but it is not recommended for people with low body weight or low blood sugar. For individuals of moderate weight, a low-dose regimen can be used.

Q2: What should I do if I encounter a period of weight loss stagnation?
The weight loss stagnation period is a self-protection mechanism of the body, which can be broken by changing exercise habits, adjusting dietary structure, and extending fasting time.

Q3: How to stop using it after reaching the target weight?
It is recommended to continue using it for another month on the current basis to allow the body to adapt to the new weight state, which can help reduce the magnitude of weight rebound after discontinuation.

Disclaimer: The information published on this website comes from the internet, which does not mean that this website agrees with its views or confirms the authenticity of the content. Please pay attention to distinguish it. In addition, the products provided by our company are only used for scientific research. We are not responsible for the consequences of any improper use.

If you are interested in our products, or have critical suggestions on our articles or are not completely satisfied with the products received, please contact us by Email ：sales6@faithfulbio.com   . Our team is committed to ensuring the complete satisfaction of customers.

Hot Tags: semaglutide peptide raw powder cas 910463-68-2, China, suppliers, manufacturers, factory, customized, wholesale, buy, price, bulk, pure, producer, discount, for sale, in stock, free sample, raw powder, raw material, made in China